Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.52 Analyst target: $18.87 Upside: 648.81%
Incannex Healthcare Limited is engaged in the research, development and sale of medicinal cannabinoid products in Australia. The company is headquartered in Sydney, Australia.
See the full interactive analysis & chart →Informational only — not investment advice.